These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22050085)

  • 41. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
    Pease JE; Wang J; Ponath PD; Murphy PM
    J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
    Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
    J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
    Zoffmann S; Chollet A; Galzi JL
    Mol Pharmacol; 2002 Sep; 62(3):729-36. PubMed ID: 12181451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
    Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
    Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.
    Kline JM; Heusinkveld LE; Taranto E; Martin CB; Tomasi AG; Hsu IJ; Cho K; Khillan JS; Murphy PM; Pontejo SM
    J Biol Chem; 2021; 296():100373. PubMed ID: 33548230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
    Peng JY; Vaidehi N; Hall SE; Goddard WA
    ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model.
    Horuk R; Shurey S; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Buckman B; Wei GP; Xu W; Liang M; Rosser M; Dunning L; Hesselgesser J; Snider RM; Morrissey MM; Perez HD; Green C
    Immunol Lett; 2001 Apr; 76(3):193-201. PubMed ID: 11306147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).
    Steen A; Sparre-Ulrich AH; Thiele S; Guo D; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2014 Mar; 171(6):1566-79. PubMed ID: 24328926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
    Perlman S; Schambye HT; Rivero RA; Greenlee WJ; Hjorth SA; Schwartz TW
    J Biol Chem; 1995 Jan; 270(4):1493-6. PubMed ID: 7829475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines.
    Dairaghi DJ; Fan RA; McMaster BE; Hanley MR; Schall TJ
    J Biol Chem; 1999 Jul; 274(31):21569-74. PubMed ID: 10419462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
    Sanchez J; Lane JR; Canals M; Stone MJ
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653.
    Norman P
    Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
    Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
    J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and discovery of a novel CCR1 antagonist.
    Naya A; Sagara Y; Ohwaki K; Saeki T; Ichikawa D; Iwasawa Y; Noguchi K; Ohtake N
    J Med Chem; 2001 Apr; 44(9):1429-35. PubMed ID: 11311066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
    Goya I; Gutiérrez J; Varona R; Kremer L; Zaballos A; Márquez G
    J Immunol; 1998 Feb; 160(4):1975-81. PubMed ID: 9469461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
    Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
    J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
    Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP
    J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The discovery of BMS-457, a potent and selective CCR1 antagonist.
    Gardner DS; Santella JB; Duncia JV; Carter PH; Dhar TG; Wu H; Guo W; Cavallaro C; Van Kirk K; Yarde M; Briceno SW; Grafstrom RR; Liu R; Patel SR; Tebben AJ; Camac D; Khan J; Watson A; Yang G; Rose A; Foster WR; Cvijic ME; Davies P; Hynes J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3833-40. PubMed ID: 23707259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3.
    Kroeze KL; Boink MA; Sampat-Sardjoepersad SC; Waaijman T; Scheper RJ; Gibbs S
    J Invest Dermatol; 2012 Jan; 132(1):216-25. PubMed ID: 21850025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.